Treatment of Parkinson's Disease, obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands

Details for Australian Patent Application No. 2006228413 (hide)

International Classifications

Event Publications

18 October 2007 PCT application entered the National Phase

PCT publication WO2006/103546 Priority application(s): WO2006/103546

15 September 2011 Application Accepted

Published as AU-B-2006228413

13 October 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 26 Sep 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

2 February 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 26 Sep 2011

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.